Alzheimer's Disease Trial, Not Yet Recruiting NCT06895525 Sponsor: Peking University First Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT06895525
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 50 and 85 years.
  • People who have recently received their first diagnosis of probable Alzheimer's disease dementia or Alzheimer's-related mild memory and thinking difficulties, based on recognised diagnostic guidelines.
  • People who scored between 22 and 30 on a standard memory and thinking test called the Mini-Mental State Examination (MMSE).
  • People who scored 0.5 or 1 on a standard dementia rating scale (CDR), with a memory-specific score of at least 0.5.
  • People who are able to follow the study procedures and attend appointments as scheduled.
  • People who are willing to take part and have given their informed consent.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have another condition known to cause dementia, such as vascular dementia or Lewy body dementia.
  • People who have a serious neurological condition, such as a history of seizures, stroke, bleeding in the brain, traumatic brain injury, or brain tumours.
  • People who have severe anxiety, depression, schizophrenia, bipolar disorder, or another psychotic condition that currently requires active treatment.
  • People who have had a problem with alcohol or drug dependence within the past year.
  • People who have allergies to the dietary supplement being studied in this trial.
  • People who are currently taking medications used to treat dementia, such as donepezil, galantamine, or memantine.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Peking University First Hospital
Registry
ClinicalTrials.gov
Start date
15 April 2025
Est. completion
31 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

Changes in Clinical Dementia Rating-Sum of Boxes (CDR-SB) from baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov